Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical Donor HCT for Sickle Cell Disease
NCT07616154Phase 2Recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Sep 2026
- Primary completion
- Sep 2034
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, nab-sirolimus, abatacept in sickle cell disease (SCD), sponsored by St. Jude Children's Research Hospital. Started Sep 2026; status: recruiting.
02
Drugs
cyclophosphamidenab-sirolimusabatacept
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT07616154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07616154.